Pasithea Therapeutics Corp. Common Stock (KTTA) Stock Price, Quote & AI Analysis
Live KTTA stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Pasithea Therapeutics Corp. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Pasithea Therapeutics Corp. Common Stock (KTTA), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Pasithea Therapeutics Corp. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Pasithea Therapeutics Corp. Common Stock Overview
Company information
Company Overview
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Pasithea Therapeutics Corp. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...